MorphoSys AG (MOR.DE)
XETRA - XETRA Delayed Price. Currency in EUR
Add to watchlist
At close: 05:36PM CEST
| Previous Close | 67.70 |
| Open | 67.70 |
| Bid | 67.70 x 1500 |
| Ask | 67.75 x 8800 |
| Day's Range | 67.70 - 67.70 |
| 52 Week Range | 14.52 - 68.00 |
| Volume | |
| Avg. Volume | 453,403 |
| Market Cap | 2.553B |
| Beta (5Y Monthly) | 0.60 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -5.53 |
| Earnings Date | Apr 29, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 56.00 |
ZacksNovartis (NVS) Inks Deal for ARVN's Prostate Cancer Candidate
Novartis (NVS) enters into a license deal with Arvinas, Inc. (ARVN) for the worldwide development and commercialization of cancer candidate ARV-766. Shares of ARVN rise on the news.
- Zacks
Novartis (NVS) to Undertake Job Cuts in Development Department
Novartis (NVS) is set to cut jobs by 680 in its development organization to reshape workforce.
ACCESSWIREMorphoSys' Management Board and Supervisory Board Recommend Shareholders Accept Public Takeover Offer by Novartis
Novartis offers € 68.00 per share in cash, representing a total equity value of € 2.7 billion Shareholders benefit from attractive premium of 94% and 142% on the volume-weighted average price during the last month and three months before January 25, ...
© 2024 Yahoo. All rights reserved.